Table 1 Baseline information of the two groups [cases (%) / x̄±s ]
Clinical Data | CCABG group (n = 52) | MICS CABG group (n = 52) | p value | |
|---|---|---|---|---|
Gender (M) | 43 (82.6) | 42 (80.8) | 0.800 | |
Age (years) | 60.83 ± 8.62 | 61.27 ± 8.94 | 0.798 | |
BMI (kg/m2) | 25.91 ± 2.67 | 25.64 ± 2.95 | 0.627 | |
Body surface area (m2) | 1.80 ± 0.17 | 1.82 ± 0.14 | 0.586 | |
History of hypertension | 35 (67.3) | 39 (75.0) | 0.387 | |
Smoking history | 34 (65.4) | 29 (55.8) | 0.316 | |
Drinking history | 21 (40.4) | 18 (34.6) | 0.543 | |
History of atrial fibrillation | 1 (1.9) | 0 (0) | 0.315 | |
History of cerebral infarction | 18 (34.6) | 19 (36.5) | 0.838 | |
History of cardiac surgery | 0 (0) | 0 (0) | - | |
NYHA grading | Level I | 0 (0) | 0 (0) | 0.873 |
Level II | 6 (11.5) | 5 (9.6) | ||
Level III | 35 (67.3) | 34 (65.4) | ||
Level IV | 11 (21.2) | 13 (25.0) | ||
Creatinine clearance rate (mL/min) | Normal | 33 (63.5) | 29 (55.8) | 0.712 |
Mild | 17 (32.3) | 21 (40.4) | ||
Moderate | 2 (3.8) | 2 (3.8) | ||
Severe | 0 (0) | 0 (0) | ||
Dialysis | 0 (0) | 0 (0) | ||
BNP (ng/L) | Normal | 44 (84.6) | 45 (86.5) | 0.523 |
Cardiac insufficiency | 8 (15.4) | 6 (11.5) | ||
Acute heart failure | 0 (0) | 1 (1.9) | ||
CK-MB (ng/ mL) | Normal | 52 (100) | 52 (100) | - |
> 2 fold | 0 (0) | 0 (0) | ||
TnI (µg/L) | Normal | 50 (96.2) | 50 (96.2) | 1.000 |
> 2 fold | 2 (3.8) | 2 (3.8) | ||
PO2 | Normal | 42 (80.8) | 42 (80.8) | 1.000 |
Mild hypoxemia | 10 (19.2) | 10 (19.2) | ||
Type I respiratory failure | 0 (0) | 0 (0) | ||
LVEF (%) | ≥ 50 | 50 (96.2) | 50 (96.2) | 1.000 |
< 50 | 2 (3.8) | 2 (3.8) | ||